부산대학교 도서관

Hamilton, E; Oliveira, M; Turner, N; García-Corbacho, J; Hernando, C; Ciruelos, EM; Kabos, P; Ruiz-Borrego, M; Armstrong, A; Patel, MR; Vaklavas, C; Twelves, C; Boni, V; Incorvati, J; Brier, T; Gibbons, L; Klinowska, T; Lindemann, JPO; Morrow, CJ; Sykes, A; Baird, RD

Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
ANNALS OF ONCOLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA

Sykes A; Clinical Pharmacology and Quantitative Pharmacology, AstraZeneca, Cambridge, UK.; Engman H; Global Product Development, Product Development and Technology, Global Operations, AstraZeneca, Gothenburg, Sweden.; Taylor N; Global Pharmaceutical Project, AstraZeneca, Macclesfield, UK.; Brier T; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Maudsley R; Oncology Biometrics, Research and Development, AstraZeneca, Cambridge, UK.; Kirova B; Oncology Patient Safety, Oncology R&D, AstraZeneca, Cambridge, UK.; Mathewson AM; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Bragg RA; Early Chemical Development, Pharmaceutical Sciences, Research and Development, AstraZeneca, Cambridge, UK.; Gränfors M; Early Product Development and Manufacturing, Pharmaceutical Sciences, Research and Development, AstraZeneca, Gothenburg, Sweden.; Gangl ET; Research and Early Development, Oncology Research and Development, AstraZeneca, Boston, Massachusetts, USA.; Klinowska T; Late Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Li Y; Research and Early Development, Oncology Research and Development, AstraZeneca, Boston, Massachusetts, USA.; Menakuru SR; Quotient Sciences, Nottingham, UK.; Roe C; Quotient Sciences, Nottingham, UK.; McDermott J; Quotient Sciences, Nottingham, UK.; Lindemann JPO; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.

Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE

Vaklavas C; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Oliveira M; Medical Oncology Department, Vall d'Hebron University Hospital and Breast Cancer Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Armstrong AC; The Christie NHS Foundation Trust and the University of Manchester, Manchester, UK.; Moreno I; START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain.; Twelves C; University of Leeds and Leeds Teaching Hospitals NHS Trust, Leeds, UK.; Victoria Ruiz I; Department of Medical Oncology, IDIBAPS, Hospital Clínic, Barcelona, Spain.; Bermejo de Las Heras B; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Brier T; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Ciardullo C; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Gibbons L; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Jack T; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Klinowska T; Late Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Lindemann JPO; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Mathewson AM; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Maudsley R; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Morrow CJ; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Sykes A; Clinical Pharmacology and Safety Sciences, Biopharmaceutical Sciences, AstraZeneca, Cambridge, UK.; Baird RD; Cancer Research UK, Cambridge Centre, Cambridge, UK. Electronic address: rdb39@cam.ac.uk.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Baird RD; Cancer Research UK, Cambridge Centre, Cambridge, United Kingdom.; Bermejo de Las Heras B; Department of Medical Oncology, Hospital Clinico Universitario de Valencia, Valencia, Spain.; Ruiz-Borrego M; Department of Medical Oncology, H U Virgen del Rocio, Seville, Spain.; Vaklavas C; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.; Moreno I; START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain.; Oliveira M; Medical Oncology Department, Vall d'Hebron University Hospital and Breast Cancer Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Armstrong A; The Christie NHS Foundation Trust and the University of Manchester, Manchester, United Kingdom.; Turner N; Cancer Now, Toby Robins Research Centre, Institute of Cancer Research, London, United Kingdom.; Incorvati J; Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Twelves C; University of Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.; Ciruelos E; Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain.; Hamilton E; Sarah Cannon Research Institute, Nashville, Tennessee.; Patel MR; Sarah Cannon Research Institute, Nashville, Tennessee.; Florida Cancer Specialists/Sarasota Memorial Hospital, Sarasota, Florida.; Kabos P; Division of Medical Oncology, University of Colorado, Boulder, Colorado.; Ciardullo C; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Klinowska T; Late Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Lindemann JPO; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Mathewson AM; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Morrow CJ; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Sykes A; Clinical Pharmacology and Safety Sciences, Biopharmaceutical Sciences, AstraZeneca, Cambridge, United Kingdom.; Yang J; Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts.; Zhang B; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Victoria I; Department of Medical Oncology, IDIBAPS, Hospital Clínic, Barcelona, Spain.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Turner, NC; Alarcón, E; Armstrong, AC; Philco, M; López Chuken, YA; Sablin, M-P; Tamura, K; Gómez Villanueva, A; Pérez-Fidalgo, JA; Cheung, SYA; Corcoran, C; Cullberg, M; Davies, BR; de Bruin, EC; Foxley, A; Lindemann, JPO; Maudsley, R; Moschetta, M; Outhwaite, E; Pass, M; Rugman, P; Schiavon, G; Oliveira, M

Ann Oncol
Scientia
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Recercat. Dipósit de la Recerca de Catalunya
instname
ANNALS OF ONCOLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Annals of oncology : official journal of the European Society for Medical Oncology

LM Smyth; M Oliveira; E Ciruelos; K Tamura; A El-Khoueiry; A Mita; B You; DJ Renouf; M-P Sablin; A Lluch; IA Mayer; H Bando; H Yamashita; H Ambrose; E de Bruin; TH Carr; C Corcoran; A Foxley; JPO Lindemann; R Maudsley; M Pass; A Rutkowski; G Schiavon; U Banerji; M Scaltriti; BS Taylor; S Chandarlapaty; J Baselga; DM Hyman

Cancer Research. 78:P5-21

Banerji, U; Dean, EJ; Pérez-Fidalgo, JA; Batist, G; Bedard, PL; You, B; Westin, SN; Kabos, P; Garrett, MD; Tall, M; Ambrose, H; Barrett, JC; Carr, TH; Cheung, SYA; Corcoran, C; Cullberg, M; Davies, BR; de Bruin, EC; Elvin, P; Foxley, A; Lawrence, P; Lindemann, JPO; Maudsley, R; Pass, M; Rowlands, V; Rugman, P; Schiavon, G; Yates, J; Schellens, JHM

Clinical cancer research : an official journal of the American Association for Cancer Research
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
CLINICAL CANCER RESEARCH
Banerji, U, Dean, E J, Alejandro Perez-Fidalgo, J, Batist, G, Bedard, P L, You, B, Westin, S N, Kabos, P, Garrett, M D, Tall, M, Ambrose, H, Carl Barrett, J, Hedley Carr, T, Amy Cheung, S Y, Corcoran, C, Cullberg, M, Davies, B R, de Bruin, E C, Elvin, P, Foxley, A, Lawrence, P, Lindemann, J P O, Maudsley, R, Pass, M, Rowlands, V, Rugman, P, Schiavon, G, Yates, J & Schellens, J H M 2018, 'A phase i open-label study to identify a dosing regimen of the pan-akt inhibitor azd5363 for evaluation in solid tumors and in pik3ca-mutated breast and gynecologic cancers', Clinical Cancer Research, vol. 24, no. 9, pp. 2050-2059. https://doi.org/10.1158/1078-0432.CCR-17-2260

Hyman, DM; Smyth, LM; Donoghue, MTA; Westin, SN; Bedard, PL; Dean, EJ; Bando, H; El-Khoueiry, AB; Pérez-Fidalgo, JA; Mita, A; Schellens, JHM; Chang, MT; Reichel, JB; Bouvier, N; Selcuklu, SD; Soumerai, TE; Torrisi, J; Erinjeri, JP; Ambrose, H; Barrett, JC; Dougherty, B; Foxley, A; Lindemann, JPO; McEwen, R; Pass, M; Schiavon, G; Berger, MF; Chandarlapaty, S; Solit, DB; Banerji, U; Baselga, J; Taylor, BS

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
JOURNAL OF CLINICAL ONCOLOGY
Hyman, D M, Smyth, L M, Donoghue, M T A, Chang, M T, Reichel, J B, Bouvier, N, Selcuklu, S D, Soumerai, T E, Torrisi, J, Erinjeri, J P, Berger, M F, Chandarlapaty, S, Solit, D B, Baselga, J, Taylor, B S, Barrett, J C, Dougherty, B, Ambrose, H, Foxley, A, Lindemann, J P O, McEwen, R, Pass, M, Schiavon, G, Dean, E J, Banerji, U, Westin, S N, Bedard, P L, Bando, H, El-Khoueiry, A B, Mita, A, Perez-Fidalgo, J A & Schellens, J H M 2017, 'AKT inhibition in solid tumors with AKT1 mutations', Journal of Clinical Oncology, vol. 35, no. 20, pp. 2251-2259. https://doi.org/10.1200/JCO.2017.73.0143

Bergh, J; Jonsson, P-E; Lidbrink, EK; Trudeau, M; Eiermann, W; Brattstrom, D; Lindemann, JPO; Wiklund, F; Henriksson, R

JOURNAL OF CLINICAL ONCOLOGY. 30(16):1919-1925

Oliveira M; Medical Oncology Department, Vall d'Hebron University Hospital and Breast Cancer Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. Electronic address: moliveira@vhio.net.; Pominchuk D; Medical Center Verum, Kyiv, Ukraine.; Nowecki Z; The Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.; Hamilton E; Sarah Cannon Research Institute, Nashville, TN, USA.; Kulyaba Y; Makiivka City Hospital of Donetsk Region, Makiivka, Ukraine.; Andabekov T; AV Medical Group, St Petersburg, Russia.; Hotko Y; Central City Hospital, Uzhgorod National University, Uzhgorod, Ukraine.; Melkadze T; Oncology and Hematology Department, Academician Fridon Todua Medical Center, Research Institute of Clinical Medicine, Tbilisi, Georgia.; Nemsadze G; The Institute of Clinical Oncology, Tbilisi, Georgia.; Neven P; Multidisciplinary Breast Center, University Hospitals Leuven, Campus Gasthuisberg, Leuven, Belgium.; Vladimirov V; Pyatigorsky Oncology Dispensary, Pyatigorsk, Russia.; Zamagni C; IRCCS Azienda Ospedaliero-universitaria di Bologna, Bologna, Italy.; Denys H; Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium.; Forget F; Centre Hospitalier de l'Ardenne-Site de Libramont, Libramont-Chevigny, Belgium.; Horvath Z; Center of Oncoradiology, Bács-Kiskun County Teaching Hospital, Kecskemét, Hungary.; Nesterova A; Republican Clinical Oncology Dispensary of the Ministry of Health of the Republic of Tatarstan, Kazan, Russia.; Ajimi M; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Kirova B; Oncology Patient Safety, Oncology R&D, AstraZeneca, Cambridge, UK.; Klinowska T; Late Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Lindemann JPO; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Lissa D; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Mathewson A; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Morrow CJ; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Traugottova Z; Parexel International, Prague, Czech Republic.; van Zyl R; Parexel International, Bloemfontein, South Africa.; Arkania E; Helsicore Israeli Georgian Medical Research Clinic, Tbilisi, Georgia.

Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Smyth LM; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Loxo Oncology Inc., Stamford, CT, USA.; Batist G; Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC, Canada.; Meric-Bernstam F; MD Anderson Cancer Center, Houston, TX, USA.; Kabos P; University of Colorado Cancer Center, Aurora, CO, USA.; Spanggaard I; Rigshospitalet, Copenhagen, Denmark.; Lluch A; Hospital Clínico Universitario de Valencia, University of Valencia, INCLIVA Biomedical Research Institute, Valencia, Spain.; Biomedical Research Centre Network in Cancer (CIBERONC), Madrid, Spain.; Jhaveri K; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Varga A; Institute Gustave Roussy, Villejuif, France.; Wong A; National University Hospital, Singapore, Singapore.; Schram AM; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Ambrose H; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Carr TH; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; de Bruin EC; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Salinas-Souza C; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Foxley A; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Hauser J; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Lindemann JPO; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Maudsley R; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; McEwen R; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Moschetta M; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Nikolaou M; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Schiavon G; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Razavi P; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Banerji U; Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK.; Baselga J; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; AstraZeneca, Gaithersburg, MD, USA.; Hyman DM; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Loxo Oncology Inc., Stamford, CT, USA.; Chandarlapaty S; Memorial Sloan Kettering Cancer Center, New York, NY, USA. chandars@mskcc.org.

Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Lawson M; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Cureton N; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Ros S; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Cheraghchi-Bashi A; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Urosevic J; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; D'Arcy S; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Delpuech O; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; DuPont M; Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts.; Fisher DI; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.; Gangl ET; Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts.; Lewis H; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Trueman D; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Wali N; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Williamson SC; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Moss J; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Montaudon E; Institut Curie, Paris, France.; Derrien H; Institut Curie, Paris, France.; Marangoni E; Institut Curie, Paris, France.; Miragaia RJ; Oncology Data Science, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Gagrica S; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Morentin-Gutierrez P; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Moss TA; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Maglennon G; Clinical Pharmacology and Safety Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.; Sutton D; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Polanski R; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.; Rosen A; Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts.; Cairns J; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.; Zhang P; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Sánchez-Guixé M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Serra V; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Critchlow SE; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Scott JS; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Lindemann JPO; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Barry ST; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Klinowska T; Late Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Morrow CJ; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Carnevalli LS; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

JFR Robertson; RE Coleman; KL Cheung; A Evans; C Holcombe; A Skene; D Rea; S Ahmed; A Jahan; S Kelly; K Horgan; P Rauchhaus; R Littleford; A Foxley; JPO Lindemann; M Pass; P Rugman; R Deb; P Finlay; JMW Gee

Cancer Research. 78:P4-04

LM Smyth; M Oliveira; E Ciruelos; K Tamura; A El-Khoueiry; A Mita; B You; DJ Renouf; M-P Sablin; A Lluch; IA Mayer; H Bando; H Yamashita; H Ambrose; E de Bruin; TH Carr; C Corcoran; A Foxley; JPO Lindemann; R Maudsley; M Pass; A Rutkowski; G Schiavon; U Banerji; M Scaltriti; BS Taylor; S Chandarlapaty; J Baselga; DM Hyman

Cancer Research. 78:P5-21

JFR Robertson; JPO Lindemann; A Llombart-Cussac; J Rolski; D Feltl; J Dewar; L Emerson; A Dean; MJ. Ellis

Cancer Research. 70:S1-3

Robertson JFR; Coleman RE; Cheung KL; Evans A; Holcombe C; Skene A; Rea D; Ahmed S; Jahan A; Horgan K; Rauchhaus P; Littleford R; Amy Cheung SY; Cullberg M; de Bruin EC; Koulai L; Lindemann JPO; Pass M; Rugman P; Schiavon G; Deb R; Finlay P; Foxley A; Gee JMW

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: PubMed not MEDLINE; MEDLINE

de Bruin EC; Personalised Healthcare and Biomarkers, Innovative Medicines and Early Development, AstraZeneca, Cambridge, United Kingdom.; Whiteley JL; Personalised Healthcare and Biomarkers, Innovative Medicines and Early Development, AstraZeneca, Cambridge, United Kingdom.; Corcoran C; Personalised Healthcare and Biomarkers, Innovative Medicines and Early Development, AstraZeneca, Cambridge, United Kingdom.; Kirk PM; Personalised Healthcare and Biomarkers, Innovative Medicines and Early Development, AstraZeneca, Cambridge, United Kingdom.; Fox JC; Personalised Healthcare and Biomarkers, Innovative Medicines and Early Development, AstraZeneca, Cambridge, United Kingdom.; Armisen J; Horizon Discovery Ltd, Cambridge, United Kingdom.; Lindemann JPO; Early Clinical Development, Innovative Medicines and Early Development, AstraZeneca, Cambridge, United Kingdom.; Schiavon G; Translational Science, Innovative Medicines and Early Development, AstraZeneca, Cambridge, United Kingdom.; Ambrose HJ; Early Clinical Development, Innovative Medicines and Early Development, AstraZeneca, Cambridge, United Kingdom.; Kohlmann A; Personalised Healthcare and Biomarkers, Innovative Medicines and Early Development, AstraZeneca, Cambridge, United Kingdom.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Yap TA; Royal Marsden Hospital, London, United Kingdom. tyap@mdanderson.org.; The Institute of Cancer Research, London, United Kingdom.; Kristeleit R; University College London, London, United Kingdom.; Michalarea V; Royal Marsden Hospital, London, United Kingdom.; Pettitt SJ; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom.; Lim JSJ; Royal Marsden Hospital, London, United Kingdom.; Carreira S; The Institute of Cancer Research, London, United Kingdom.; Roda D; Royal Marsden Hospital, London, United Kingdom.; The Institute of Cancer Research, London, United Kingdom.; Miller R; University College London, London, United Kingdom.; Riisnaes R; The Institute of Cancer Research, London, United Kingdom.; Miranda S; The Institute of Cancer Research, London, United Kingdom.; Figueiredo I; The Institute of Cancer Research, London, United Kingdom.; Rodrigues DN; The Institute of Cancer Research, London, United Kingdom.; Ward S; Royal Marsden Hospital, London, United Kingdom.; The Institute of Cancer Research, London, United Kingdom.; Matthews R; Royal Marsden Hospital, London, United Kingdom.; The Institute of Cancer Research, London, United Kingdom.; Parmar M; Royal Marsden Hospital, London, United Kingdom.; The Institute of Cancer Research, London, United Kingdom.; Turner A; Royal Marsden Hospital, London, United Kingdom.; The Institute of Cancer Research, London, United Kingdom.; Tunariu N; Royal Marsden Hospital, London, United Kingdom.; Chopra N; Royal Marsden Hospital, London, United Kingdom.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.; Gevensleben H; The Institute of Cancer Research, London, United Kingdom.; Turner NC; Royal Marsden Hospital, London, United Kingdom.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.; Ruddle R; The Institute of Cancer Research, London, United Kingdom.; Raynaud FI; The Institute of Cancer Research, London, United Kingdom.; Decordova S; The Institute of Cancer Research, London, United Kingdom.; Swales KE; The Institute of Cancer Research, London, United Kingdom.; Finneran L; The Institute of Cancer Research, London, United Kingdom.; Hall E; The Institute of Cancer Research, London, United Kingdom.; Rugman P; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Lindemann JPO; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Foxley A; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Lord CJ; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom.; Banerji U; Royal Marsden Hospital, London, United Kingdom.; The Institute of Cancer Research, London, United Kingdom.; Plummer R; Clinical and Translational Research Institute, Newcastle University, Newcastle, United Kingdom.; Basu B; Department of Oncology, University of Cambridge, Cambridge, United Kingdom.; Lopez JS; Royal Marsden Hospital, London, United Kingdom.; The Institute of Cancer Research, London, United Kingdom.; Drew Y; Clinical and Translational Research Institute, Newcastle University, Newcastle, United Kingdom.; de Bono JS; Royal Marsden Hospital, London, United Kingdom.; The Institute of Cancer Research, London, United Kingdom.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Robertson JFR; University of Nottingham, Nottingham, United Kingdom. john.robertson@nottingham.ac.uk.; Evans A; Poole Hospital, Poole, United Kingdom.; Henschen S; Helios Clinics Schwerin, Schwerin, Germany.; Kirwan CC; University of Manchester, Manchester, United Kingdom.; Jahan A; King's Mill Hospital, Mansfield, United Kingdom.; Kenny LM; Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom.; Dixon JM; Western General Hospital, Edinburgh, United Kingdom.; Schmid P; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.; Kothari A; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; Mohamed O; Johannes Wesling General Hospital, Minden, Germany.; Fasching PA; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Nuremberg, Germany.; Cheung KL; University of Nottingham, Nottingham, United Kingdom.; Wuerstlein R; Breast Center, Department of Obstetrics and Gynecology and Comprehensive Cancer Center, University of Munich (LMU), Munich, Germany.; Carroll D; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Klinowska T; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Lindemann JPO; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; MacDonald A; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.; Mather R; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Maudsley R; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Moschetta M; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Nikolaou M; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Roudier MP; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Sarvotham T; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Schiavon G; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Zhou D; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.; Zhou L; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.; Harbeck N; Breast Center, Department of Obstetrics and Gynecology and Comprehensive Cancer Center, University of Munich (LMU), Munich, Germany.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Smyth LM; Memorial Sloan Kettering Cancer Center, New York, New York. lilsmyth@svhg.ie.; Tamura K; National Cancer Center Hospital, Tokyo, Japan.; Oliveira M; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Ciruelos EM; Hospital Universitario 12 de Octubre, Madrid, Spain.; Mayer IA; Vanderbilt Breast Center, Nashville, Tennessee.; Sablin MP; Institut Curie, Paris, France.; Biganzoli L; Breast Centre, Oncology Department, Hospital of Prato, Prato, Italy.; Ambrose HJ; R&D Oncology, AstraZeneca, Cambridge, United Kingdom.; Ashton J; R&D Oncology, AstraZeneca, Cambridge, United Kingdom.; Barnicle A; R&D Oncology, AstraZeneca, Cambridge, United Kingdom.; Cashell DD; R&D Oncology, AstraZeneca, Cambridge, United Kingdom.; Corcoran C; R&D Oncology, AstraZeneca, Cambridge, United Kingdom.; de Bruin EC; R&D Oncology, AstraZeneca, Cambridge, United Kingdom.; Foxley A; R&D Oncology, AstraZeneca, Cambridge, United Kingdom.; Hauser J; R&D Oncology, AstraZeneca, Cambridge, United Kingdom.; Lindemann JPO; R&D Oncology, AstraZeneca, Cambridge, United Kingdom.; Maudsley R; R&D Oncology, AstraZeneca, Cambridge, United Kingdom.; McEwen R; R&D Oncology, AstraZeneca, Cambridge, United Kingdom.; Moschetta M; R&D Oncology, AstraZeneca, Cambridge, United Kingdom.; Pass M; R&D Oncology, AstraZeneca, Cambridge, United Kingdom.; Rowlands V; R&D Oncology, AstraZeneca, Cambridge, United Kingdom.; Schiavon G; R&D Oncology, AstraZeneca, Cambridge, United Kingdom.; Banerji U; Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom.; Scaltriti M; Memorial Sloan Kettering Cancer Center, New York, New York.; Taylor BS; Memorial Sloan Kettering Cancer Center, New York, New York.; Chandarlapaty S; Memorial Sloan Kettering Cancer Center, New York, New York.; Baselga J; Memorial Sloan Kettering Cancer Center, New York, New York.; Hyman DM; Memorial Sloan Kettering Cancer Center, New York, New York.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE